Saudi Arabia: Antisera Market 2024

Antisera Market Size in Saudi Arabia

In 2021, the Saudi antisera market increased by 29% to $X, rising for the third consecutive year after three years of decline. Over the period under review, consumption recorded significant growth. Over the period under review, the market hit record highs in 2021 and is likely to continue growth in years to come.

Antisera Exports

Exports from Saudi Arabia

In 2021, the amount of antisera and other blood fractions exported from Saudi Arabia surged to X tons, with an increase of 29% against 2020. In general, exports enjoyed a significant increase. The growth pace was the most rapid in 2014 with an increase of 1,755% against the previous year. The exports peaked at X tons in 2018; however, from 2019 to 2021, the exports failed to regain momentum.

In value terms, antisera exports reduced rapidly to $X in 2021. Over the period under review, exports saw strong growth. The pace of growth was the most pronounced in 2014 when exports increased by 876% against the previous year. Over the period under review, the exports attained the peak figure at $X in 2018; however, from 2019 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

Bahrain (X tons) was the main destination for antisera exports from Saudi Arabia, accounting for a 61% share of total exports. Moreover, antisera exports to Bahrain exceeded the volume sent to the second major destination, Germany (X tons), twofold. The third position in this ranking was taken by Kuwait (X tons), with an 8.7% share.

From 2012 to 2021, the average annual growth rate of volume to Bahrain stood at +25.7%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (+24.2% per year) and Kuwait (+9.9% per year).

In value terms, Bahrain ($X), Kuwait ($X) and Germany ($X) were the largest markets for antisera exported from Saudi Arabia worldwide, together accounting for 99% of total exports.

Bahrain, with a CAGR of +48.8%, saw the highest rates of growth with regard to the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average antisera export price stood at $X per ton in 2021, reducing by -46% against the previous year. In general, the export price faced a abrupt descent. The most prominent rate of growth was recorded in 2019 when the average export price increased by 133%. Over the period under review, the average export prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2021, the export prices remained at a lower figure.

Prices varied noticeably country of destination: the country with the highest price was Oman ($X per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Bahrain (+18.4%), while the prices for the other major destinations experienced mixed trend patterns.

Antisera Imports

Imports into Saudi Arabia

In 2021, approx. X tons of antisera and other blood fractions were imported into Saudi Arabia; picking up by 13% compared with the previous year. In general, imports posted significant growth. The pace of growth was the most pronounced in 2020 with an increase of 106% against the previous year. Imports peaked in 2021 and are expected to retain growth in the immediate term.

In value terms, antisera imports surged to $X in 2021. Overall, imports saw a significant increase. The growth pace was the most rapid in 2020 when imports increased by 92% against the previous year. Over the period under review, imports reached the maximum in 2021 and are likely to see steady growth in years to come.

Imports by Country

Germany (X tons), the United States (X tons) and Italy (X tons) were the main suppliers of antisera imports to Saudi Arabia, with a combined 59% share of total imports.

From 2012 to 2021, the biggest increases were recorded for the United States (with a CAGR of +52.0%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Germany ($X) constituted the largest supplier of antisera and other blood fractions to Saudi Arabia, comprising 43% of total imports. The second position in the ranking was held by Switzerland ($X), with a 17% share of total imports. It was followed by the United States, with a 12% share.

From 2012 to 2021, the average annual growth rate of value from Germany stood at +30.5%. The remaining supplying countries recorded the following average annual rates of imports growth: Switzerland (+59.3% per year) and the United States (+55.9% per year).

Import Prices by Country

The average antisera import price stood at $X per ton in 2021, with an increase of 25% against the previous year. In general, import price indicated a pronounced increase from 2012 to 2021: its price increased at an average annual rate of +4.7% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2013 when the average import price increased by 63% against the previous year. As a result, import price reached the peak level of $X per ton. From 2014 to 2021, the average import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Switzerland ($X per ton), while the price for the UK ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Germany (+12.7%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :